its not significant because its expected on the exponential curce? pic.twitter.com/cyae6JSIPw
— Chubby♨️ (@kimmonismus) 14 avril 2026
its not significant because its expected on the exponential curce?
@kimmonismus
-
Is exponential curve growth significance really expected?
By
–
-
Chinese AI Models Six Months Behind US Frontier Labs
By
–
The question that's currently on my mind is this: Chinese models are about six months behind those of US Frontier Labs. Does this also apply to "Mythos"? Is it foreseeable that, for example, Qwen will release a similarly significant model as Claude "Mythos" in six months, or are
-
AI Consciousness: Kurzweil Predicts Indistinguishability Soon
By
–
Ray Kurzweil: AI will soon become indistinguishable from conscious beings. While it's hard to tell now, as AI continues to exhibit all the signs of consciousness, we'll eventually accept it as reality. The delay won't be long.
— Chubby♨️ (@kimmonismus) 14 avril 2026
The year 2026 will be marked by a resurgence of new… pic.twitter.com/D14Bwrn2pRRay Kurzweil: AI will soon become indistinguishable from conscious beings. While it's hard to tell now, as AI continues to exhibit all the signs of consciousness, we'll eventually accept it as reality. The delay won't be long. The year 2026 will be marked by a resurgence of new
-
OpenAI CRO’s Leaked Memo Accuses Anthropic of Inflating Claims
By
–
Leaked memo: OpenAI's Chief Revenue Officer Denise Dresser just dropped a four-page internal memo that reads less like corporate strategy and more like a declaration of war against Anthropic. Leaked memo-highlights screenshotted. The key accusations: Anthropic allegedly inflates
-
Hoping for a Spud-nik Moment Today
By
–
Let’s hope for the spud-nik moment today. pic.twitter.com/S7st5loXCd
— Chubby♨️ (@kimmonismus) 14 avril 2026Let’s hope for the spud-nik moment today.
-
Anthropic Enables Mid-Chat Model Switching Feature
By
–
Antropic is rolling out switching models mid-chat. About time.
-
Claude Mythos Impresses with Exceptional Capabilities
By
–
Holy, Anthropic did not exaggerate. Claude Mythos is built different.
-
Daraxonrasib Shows Promise Doubling Pancreatic Cancer Survival
By
–
Your daily dose of good news: Revolution Medicines says its potential breakthrough pancreatic cancer drug succeeds in late-stage trial Experimental drug daraxonrasib delivered stunning Phase 3 results, nearly doubling survival (13.2 vs. 6.7 months) and cutting the risk of death
-
X Platform Quality Concerns: Risk of TikTok-like Degeneration
By
–
Because Twitter/X is currently the best platform for exchanging ideas and having important discussions. And there's a legitimate concern that X will degenerate into the next TikTok.